Literature DB >> 2542613

T-cell-mediated clearance of mouse hepatitis virus strain JHM from the central nervous system.

M A Sussman1, R A Shubin, S Kyuwa, S A Stohlman.   

Abstract

Clearance of the neurotropic JHM strain of mouse hepatitis virus from the central nervous system was examined by the transfer of spleen cells from immunized donors. A T cell with the surface phenotype of Thy1.2+ CD4+ CD8- asialo-GM1+ Mac-1- was found to be necessary for viral clearance. The surface phenotype and adherence to nylon wool suggest that these cells are activated helper-inducer T cells. Adoptive transfer to congenic histocompatibility strains demonstrated the necessity for compatibility at the D locus of the major histocompatibility complex. The expression of the CD4 surface marker and the requirement for major histocompatibility complex class I were further studied by the transfer of cells to recipients treated with anti-CD4 or anti-CD8 monoclonal antibodies. Treatment of recipients with either the anti-CD8 or the anti-CD4 antibodies inhibited virus clearance from the central nervous system. This suggests that the CD4+ cell acts as a helper and that virus is cleared from the central nervous system. This suggests that the CD4+ cell acts as a helper and that virus is cleared from the central nervous system by CD8+ cells that recognize viral antigen in the context of the H-2Db gene product.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2542613      PMCID: PMC250860     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Pathogenesis of demyelination induced by a mouse hepatitis.

Authors:  L P Weiner
Journal:  Arch Neurol       Date:  1973-05

2.  Hybridoma antibodies to the murine coronavirus JHM: characterization of epitopes on the peplomer protein (E2).

Authors:  H Wege; R Dörries; H Wege
Journal:  J Gen Virol       Date:  1984-11       Impact factor: 3.891

3.  Mechanism of demyelination in JHM virus encephalomyelitis. Electron microscopic studies.

Authors:  P W Lampert; J K Sims; A J Kniazeff
Journal:  Acta Neuropathol       Date:  1973-03-30       Impact factor: 17.088

4.  In vivo and in vitro models of demyelinating diseases. III. JHM virus infection of rats.

Authors:  O Sorensen; D Perry; S Dales
Journal:  Arch Neurol       Date:  1980-08

5.  Natural killer cell activity during mouse hepatitis virus infection: response in the absence of interferon.

Authors:  S A Stohlman; P R Brayton; R C Harmon; D Stevenson; R G Ganges; G K Matsushima
Journal:  Int J Cancer       Date:  1983-03-15       Impact factor: 7.396

6.  Effect of immune heterozygous spleen cell transfer on resistance to mouse hepatitis virus infection in nude mice.

Authors:  C Kai; T Tamura; K Fujiwara
Journal:  Microbiol Immunol       Date:  1981       Impact factor: 1.955

7.  Experimental demyelination induced by coronavirus JHM (MHV-4): molecular identification of a viral determinant of paralytic disease.

Authors:  J O Fleming; M D Trousdale; J Bradbury; S A Stohlman; L P Weiner
Journal:  Microb Pathog       Date:  1987-07       Impact factor: 3.738

8.  Monoclonal antibodies to the matrix (E1) glycoprotein of mouse hepatitis virus protect mice from encephalitis.

Authors:  J O Fleming; R A Shubin; M A Sussman; N Casteel; S A Stohlman
Journal:  Virology       Date:  1989-01       Impact factor: 3.616

9.  Late onset, symptomatic, demyelinating encephalomyelitis in mice infected with MHV-JHM in the presence of maternal antibody.

Authors:  S Perlman; R Schelper; E Bolger; D Ries
Journal:  Microb Pathog       Date:  1987-03       Impact factor: 3.738

10.  Virus persistence and recurring demyelination produced by a temperature-sensitive mutant of MHV-4.

Authors:  R L Knobler; P W Lampert; M B Oldstone
Journal:  Nature       Date:  1982-07-15       Impact factor: 49.962

View more
  50 in total

1.  Disassociation between the in vitro and in vivo effects of nitric oxide on a neurotropic murine coronavirus.

Authors:  T E Lane; A D Paoletti; M J Buchmeier
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

2.  Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+ T cells.

Authors:  J S Williamson; S A Stohlman
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

3.  Mouse hepatitis virus is cleared from the central nervous systems of mice lacking perforin-mediated cytolysis.

Authors:  M T Lin; S A Stohlman; D R Hinton
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

4.  Astrocyte-derived CXCL10 drives accumulation of antibody-secreting cells in the central nervous system during viral encephalomyelitis.

Authors:  Timothy W Phares; Stephen A Stohlman; David R Hinton; Cornelia C Bergmann
Journal:  J Virol       Date:  2013-01-09       Impact factor: 5.103

5.  Both spike and background genes contribute to murine coronavirus neurovirulence.

Authors:  Kathryn T Iacono; Lubna Kazi; Susan R Weiss
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

6.  Specific cytotoxic T lymphocytes are involved in in vivo clearance of infectious bronchitis virus.

Authors:  S H Seo; E W Collisson
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

7.  A central role for CD4(+) T cells and RANTES in virus-induced central nervous system inflammation and demyelination.

Authors:  T E Lane; M T Liu; B P Chen; V C Asensio; R M Samawi; A D Paoletti; I L Campbell; S L Kunkel; H S Fox; M J Buchmeier
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

8.  The murine coronavirus nucleocapsid gene is a determinant of virulence.

Authors:  Timothy J Cowley; Simon Y Long; Susan R Weiss
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

9.  A mechanism of virus-induced demyelination.

Authors:  Jayasri Das Sarma
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-06-21

10.  NKG2D receptor signaling enhances cytolytic activity by virus-specific CD8+ T cells: evidence for a protective role in virus-induced encephalitis.

Authors:  Kevin B Walsh; Lewis L Lanier; Thomas E Lane
Journal:  J Virol       Date:  2007-12-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.